0001240679-17-000035.txt : 20170906
0001240679-17-000035.hdr.sgml : 20170906
20170906163401
ACCESSION NUMBER: 0001240679-17-000035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170901
FILED AS OF DATE: 20170906
DATE AS OF CHANGE: 20170906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHAFFER MICHAEL I
CENTRAL INDEX KEY: 0001250730
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13738
FILM NUMBER: 171071720
MAIL ADDRESS:
STREET 1: C/O PAYCHEMEDICS CORP
STREET 2: 1280 MASSACHUSETTS AVE STE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PSYCHEMEDICS CORP
CENTRAL INDEX KEY: 0000806517
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 581701987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 125 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
BUSINESS PHONE: 978-206-8220
MAIL ADDRESS:
STREET 1: 125 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-09-01
0000806517
PSYCHEMEDICS CORP
PMD
0001250730
SCHAFFER MICHAEL I
C/O PSYCHEMEDICS CORPORATION
125 NAGOG PARK
ACTON
MA
01720
0
1
0
0
VP of Laboratory Operations
Common Stock, $.005 Par Value
2017-09-01
4
S
0
981
21.16
D
41273
D
Common Stock, $.005 Par Value
2017-09-05
4
S
0
4400
20.37
D
36873
D
Common Stock, $.005 Par Value
2017-09-06
4
S
0
2167
20.14
D
34706
D
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.00 to $21.22, inclusive. The reporting person undertakes to provide to Psychemedics Corp., any security holder of Psychemedics Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.26 to $20.54, inclusive. The reporting person undertakes to provide to Psychemedics Corp., any security holder of Psychemedics Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Includes an additional 188 shares acquired since May 23, 2017 under the Company's Dividend Reinvestment Plan.
Patrick J. Kinney, Jr. as attorney-in-fact for Michael I. Schaffer
2017-09-06